ATE316098T1 - Malaria polypeptide - Google Patents

Malaria polypeptide

Info

Publication number
ATE316098T1
ATE316098T1 AT98945703T AT98945703T ATE316098T1 AT E316098 T1 ATE316098 T1 AT E316098T1 AT 98945703 T AT98945703 T AT 98945703T AT 98945703 T AT98945703 T AT 98945703T AT E316098 T1 ATE316098 T1 AT E316098T1
Authority
AT
Austria
Prior art keywords
malaria
receptors
acting
relates
ligands
Prior art date
Application number
AT98945703T
Other languages
English (en)
Inventor
Mats Wahlgren
Antonio Barragan
Johan Carlson
Chen Qijun
Victor Fernandez
Original Assignee
Mats Wahlgren
Chen Qijun
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mats Wahlgren, Chen Qijun filed Critical Mats Wahlgren
Application granted granted Critical
Publication of ATE316098T1 publication Critical patent/ATE316098T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98945703T 1997-09-19 1998-09-18 Malaria polypeptide ATE316098T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9703386A SE9703386D0 (sv) 1997-09-19 1997-09-19 Malaria polypeptides

Publications (1)

Publication Number Publication Date
ATE316098T1 true ATE316098T1 (de) 2006-02-15

Family

ID=20408305

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98945703T ATE316098T1 (de) 1997-09-19 1998-09-18 Malaria polypeptide

Country Status (8)

Country Link
US (1) US7125958B1 (de)
EP (1) EP1015483B1 (de)
AT (1) ATE316098T1 (de)
AU (1) AU747741B2 (de)
DE (1) DE69833265T2 (de)
ES (1) ES2257818T3 (de)
SE (1) SE9703386D0 (de)
WO (1) WO1999015557A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018017996A1 (en) * 2016-07-22 2018-01-25 University Of Washington Identification and production of high affinity igm antibodies and derivatives thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9003181D0 (sv) * 1990-10-04 1990-10-04 Kabivitrum Ab Use of heparin fraction
AU694142B2 (en) * 1993-09-10 1998-07-16 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
US5993827A (en) * 1993-09-10 1999-11-30 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
US5911991A (en) * 1993-10-21 1999-06-15 New York Blood Center, Inc. Malarial binding site in duffy blood group protein
FR2732219B1 (fr) 1995-03-27 1997-05-30 Pasteur Institut Compositions pharmaceutiques pour la prevention et le traitement du paludisme, a base d'un membre de la famille des chondroitine-glycosaminoglycanes
WO1996033736A1 (en) 1995-04-27 1996-10-31 Affymax Technologies N.V. Malaria peptides and vaccines
US6120770A (en) * 1997-09-12 2000-09-19 University Of Notre Dame Du Lac Plasmodium proteins useful for preparing vaccine compositions
US6673601B1 (en) * 1999-04-15 2004-01-06 Institut Pasteur Chimeric lyssavirus nucleic acids and polypeptides
WO2001016326A2 (en) * 1999-09-01 2001-03-08 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (pfemp1) that mediates adhesion to chondroitin sulfate a
GB0019375D0 (en) * 2000-08-07 2000-09-27 Int Centre Genetic Eng & Bio Method of polypeptide renaturation
WO2002078603A2 (en) * 2001-04-02 2002-10-10 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Plasmodium falciparum erythrocyte binding protein baebl for use as a vaccine
US20060088501A1 (en) * 2004-10-21 2006-04-27 New York Blood Center, Inc. Duffy antigen receptor for chemokines and use thereof

Also Published As

Publication number Publication date
DE69833265T2 (de) 2006-09-28
US7125958B1 (en) 2006-10-24
WO1999015557A1 (en) 1999-04-01
EP1015483A1 (de) 2000-07-05
EP1015483B1 (de) 2006-01-18
ES2257818T3 (es) 2006-08-01
AU9288498A (en) 1999-04-12
AU747741B2 (en) 2002-05-23
SE9703386D0 (sv) 1997-09-19
DE69833265D1 (de) 2006-04-06

Similar Documents

Publication Publication Date Title
IT8367525A0 (it) Proteina ibrida comprendente frammenti proteici collegati da legami peptidici e relativo gene di fusione composizione contenente tale proteina
CY1117551T1 (el) Μεθοδος ελεγχου της δραστικοτητας ανοσολογικα λειτουργικου μοριου
DE69534235D1 (de) Cytokin lerk-7
TR200000654T2 (tr) KAY-Yeni bir bağışıklık sistemi proteini.
EP2272859A3 (de) Immunologische Herpes-Simplex Antigene und Verfahren zu ihrer Verwendung
ATE412430T1 (de) Monoklonale antikörper die ligandbindung an den cd22-rezeptor in reifen b-zellen unterbinden.
BR0013231A (pt) Complexos citocina-anticorpo múltiplos
UA27763C2 (uk) Рекомбінантна молекула днк, що кодує молекулу адгезії icam-3, молекула адгезії icam-3, антитіло, здатне зв'язуватись з такою молекулою, фармацевтична композиція
DE69824719D1 (de) Cytokinähnlicher faktor-7 aus säugetieren
AU6832398A (en) Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof
EE9900146A (et) Lahustuvad lümfotoksiin-ß retseptorid, lümfotoksiini retseptori vastased antikehad ja lümfotoksiini ligandi vastased antikehad terapeutiliste agensitena immunoloogiliste haiguste raviks
ES2123973T3 (es) Afamina: una proteina similar a la seroalbumina humana.
EA199800230A1 (ru) Тетрагидрохинолины в качестве антагонистов nmda (n-метил-d-аспарагиновой кислоты)
TR200102877T2 (tr) İmmünoglobulinin kendi yüksek afinite reseptörüne bağlanmasını inhibe eden antikorlara karşı anti-idiotipik antikorlar.
ATE285474T1 (de) Haemophilus adhäsionsproteinen
ATE316098T1 (de) Malaria polypeptide
ATE207935T1 (de) Antikörper gegen ein, einen histidin-anteil aufweisendes fusionspolypeptid
EA199700223A1 (ru) Бициклические антагонисты тахикининов, их получение и применение в фармацевтической композиции
DE3485219D1 (de) Tgf-polypeptide, davon derivierte antigene oligopeptide, davon erhaltene antikoerper.
DE69122103D1 (de) Antigerinnungspeptide
IT1284870B1 (it) Peptidi dei complessi tlp da carcinomi dell'apparato urogenitale e anticorpi diretti contro di essi
EA199801032A1 (ru) Белки zona pellucida для контрацепции
TR199902605T2 (xx) Fibrinojenin azalt�lma y�ntemleri.
EE9900272A (et) Uudsed IFN-retseptoriga 1 seonduvad valgud, neid kodeeriv DNA ja interferoonidele suunatud raku vastuse moduleerimise meetodid
EA199900934A1 (ru) Применение микрочастиц, содержащих адсорбированные на них белок и антитела, для получения фармацевтической композиции для интраназального введения

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1015483

Country of ref document: EP

REN Ceased due to non-payment of the annual fee